methylmalonic acid has been researched along with Benign Neoplasms, Brain in 2 studies
Methylmalonic Acid: A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA.
methylmalonic acid : A dicarboxylic acid that is malonic acid in which one of the methylene hydrogens is substituted by a methyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten patients with brain metastases treated with WBRT at 30 Gy in ten daily fractions were enrolled in this trial." | 2.77 | Assessment of response of brain metastases to radiotherapy by PET imaging of apoptosis with ¹⁸F-ML-10. ( Allen, AM; Ben-Ami, M; Davidson, T; Djaldetti, R; Fenig, E; Inbar, E; Kundel, Y; Reshef, A; Steinmetz, A; Ziv, I, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oborski, MJ | 1 |
| Laymon, CM | 1 |
| Lieberman, FS | 1 |
| Drappatz, J | 1 |
| Hamilton, RL | 1 |
| Mountz, JM | 1 |
| Allen, AM | 1 |
| Ben-Ami, M | 1 |
| Reshef, A | 1 |
| Steinmetz, A | 1 |
| Kundel, Y | 1 |
| Inbar, E | 1 |
| Djaldetti, R | 1 |
| Davidson, T | 1 |
| Fenig, E | 1 |
| Ziv, I | 1 |
1 trial available for methylmalonic acid and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Assessment of response of brain metastases to radiotherapy by PET imaging of apoptosis with ¹⁸F-ML-10.
Topics: Adult; Aged; Apoptosis; Biological Transport; Brain Neoplasms; Female; Humans; Magnetic Resonance Im | 2012 |
1 other study available for methylmalonic acid and Benign Neoplasms, Brain
| Article | Year |
|---|---|
First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy.
Topics: Aged; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Dacarbazine; Glioblastoma; Huma | 2014 |